These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 28711406)

  • 1. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H; Endo T
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDP-glycerol inhibits the synthesis of the functional
    Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
    J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycobiology of α-dystroglycan and muscular dystrophy.
    Endo T
    J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.
    Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T
    J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian O-mannosyl glycans: Biochemistry and glycopathology.
    Endo T
    Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(1):39-51. PubMed ID: 30643095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent Advances in α-dystroglycanopathy].
    Kuga A; Kanagawa M; Toda T
    Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.
    Dwyer CA; Katoh T; Tiemeyer M; Matthews RT
    J Biol Chem; 2015 Apr; 290(16):10256-73. PubMed ID: 25737452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects].
    Endo T
    Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, function and pathology of O-mannosyl glycans.
    Endo T
    Glycoconj J; 2004; 21(1-2):3-7. PubMed ID: 15467391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review.
    Taniguchi-Ikeda M; Morioka I; Iijima K; Toda T
    Mol Aspects Med; 2016 Oct; 51():115-24. PubMed ID: 27421908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.
    Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J
    Mol Vis; 2018; 24():43-58. PubMed ID: 29416295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycomic analyses of mouse models of congenital muscular dystrophy.
    Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
    J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies.
    Muntoni F; Torelli S; Wells DJ; Brown SC
    Curr Opin Neurol; 2011 Oct; 24(5):437-42. PubMed ID: 21825985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital muscular dystrophies involving the O-mannose pathway.
    Martin PT
    Curr Mol Med; 2007 Jun; 7(4):417-25. PubMed ID: 17584082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-mannosyl glycans in mammals.
    Endo T
    Biochim Biophys Acta; 1999 Dec; 1473(1):237-46. PubMed ID: 10580142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy.
    Kuwabara N; Imae R; Manya H; Tanaka T; Mizuno M; Tsumoto H; Kanagawa M; Kobayashi K; Toda T; Senda T; Endo T; Kato R
    Nat Commun; 2020 Jan; 11(1):303. PubMed ID: 31949166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle.
    Nilsson J; Nilsson J; Larson G; Grahn A
    Glycobiology; 2010 Sep; 20(9):1160-9. PubMed ID: 20507882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.